Preclinical evaluation of Sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastases

Preclinical evaluation of Sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastases

<p>Abstract</p> <p>Background</p> <p>A substantial number of breast cancer patients are identified as being at high risk of developing metastatic disease. With increasing number of targeted therapeutics entering clinical trials, chronic administration of these agents ma...

Full description

Bibliographic Details
Main Authors: Schem Christian, Bauerschlag Dirk, Bender Sascha, Lorenzen Ann-Christin, Loermann Daniel, Hamann Sigrid, Rösel Frank, Kalthoff Holger, Glüer Claus C, Jonat Walter, Tiwari Sanjay
Format: Article
Language:English
Published: BMC 2013-01-01
Series:BMC Cancer
Subjects:
Sunitinib
Bone metastases
Breast cancer
Imaging
Online Access:http://www.biomedcentral.com/1471-2407/13/32

Similar Items

Similar Items